Cite
Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer.
MLA
Zielinski, C., et al. “Rationale for Targeting the Immune System through Checkpoint Molecule Blockade in the Treatment of Non-Small-Cell Lung Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 24, no. 5, May 2013, pp. 1170–79. EBSCOhost, https://doi.org/10.1093/annonc/mds647.
APA
Zielinski, C., Knapp, S., Mascaux, C., & Hirsch, F. (2013). Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 24(5), 1170–1179. https://doi.org/10.1093/annonc/mds647
Chicago
Zielinski, C, S Knapp, C Mascaux, and F Hirsch. 2013. “Rationale for Targeting the Immune System through Checkpoint Molecule Blockade in the Treatment of Non-Small-Cell Lung Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 24 (5): 1170–79. doi:10.1093/annonc/mds647.